Global healthcare company STADA committed to investing more than €85 million in a state-of-the-art manufacturing facility in Saudi Arabia. The facility will supply essential medicines for conditions such as heart disease and diabetes to Saudi Arabia’s 35 million inhabitants, as well as to patients in surrounding count…
Axplora, a global CDMO Partner for complex small molecules and antibody-drug conjugates (ADCs), announced a multi-million-euro investment to expand lyophilization (freeze-drying) capabilities at its Le Mans, France Site strengthening its ability to deliver reliable, efficient and fast ADC manufacturing for biotech and…
Johnson & Johnson, healthcare’s leading, most comprehensive innovation powerhouse, announced a more than $1 billion investment in a next generation cell therapy manufacturing facility in Montgomery County, Pennsylvania. This new facility will further expand the Company’s U.S. manufacturing capacity as it advances …
FUJIFILM Biotechnologies, a world leading contract development and manufacturing organisation (CDMO) for biologics, vaccines, and advanced therapies, celebrated the grand opening of its expanded site in Teesside, UK,. The significantly expanded presence, funded through a total investment of approximately £400m from FU…
SOPHiA GENETICS, a global leader in AI-driven precision medicine, announced the addition of two of the largest U.S. healthcare systems to its network. The two new institutions, which collectively analyze millions of genetic samples annually, include one of the leading nonprofit, multi-region integrated healthcare sys…
Precision for Medicine (Precision), a global leader in biomarker-driven clinical research and development, has announced the opening of a new office in Singapore. This strategic expansion strengthens Precision's significant presence across the Asia-Pacific (APAC) region, serving as a crucial hub for enhanced client su…
Slingshot Biosciences, the pioneer of synthetic cell mimic technology for flow cytometry controls, announced its further expansion into the United Kingdom and European Union markets. This investment provides the product innovators in the region with broader access and faster adoption of Slingshot's reproducible, premi…
Eli Lilly and Company announced plans to invest more than $3.5 billion in a new manufacturing facility in the Lehigh Valley, Pennsylvania. The site will serve as Lilly's newest injectable medicine and device manufacturing facility that will produce next-generation weight-loss therapies, including retatrutide, a first-…
DHL Group has announced the expansion of its life sciences arm—DHL Health Logistics—with the development of a €10 million Pharmaceutical Hub in Singapore. This investment bolsters regional Life Sciences and Healthcare (LSHC) infrastructure. As a global leader in international logistics, DHL Express provides extensive…
Sisram Medical Ltd, a global wellness group offering Energy-Based Devices (EBD), injectables, and other complementary solutions, announced that its wholly-owned subsidiary, Sisram Medical China (Tianjin) Ltd., has entered into a memorandum of understanding ("MOU") with Sinmait Medical Technology (Beijing) Co., Ltd., a…
Page 12 of 60